{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:47:44Z","timestamp":1740178064783,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T00:00:00Z","timestamp":1478217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000276","name":"Department of Health","doi-asserted-by":"publisher","award":["RNC\/023\/001"],"award-info":[{"award-number":["RNC\/023\/001"]}],"id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics Open"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s41669-016-0001-4","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T03:31:41Z","timestamp":1478230301000},"page":"99-108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process"],"prefix":"10.1007","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-8321","authenticated-orcid":false,"given":"Eva","family":"Kaltenthaler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Hill-McManus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Scope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micah","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Tappenden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerys","family":"Woolacott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,4]]},"reference":[{"key":"1_CR1","unstructured":"National Institute for Health and Care Excellence. Guide to the processes of technology appraisal. NICE. 2014. \n                        https:\/\/www.nice.org.uk\/article\/pmg19\/chapter\/Acknowledgements\n                        \n                    . Accessed 25 March 2015."},{"key":"1_CR2","unstructured":"National Institute for Health and Care Excellence. Guide to the methods of technology appraisal. NICE. 2013. \n                        https:\/\/www.nice.org.uk\/article\/pmg9\/chapter\/Foreword\n                        \n                    . Acessed 4 Aug 2015."},{"issue":"3","key":"1_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S0266462313000330","volume":"29","author":"R Wong","year":"2013","unstructured":"Wong R, Paisley S, Carroll C. Assessing searches in NICE single technology appraisals: practice and checklist. Int J Technol Assess Health Care. 2013;29(3):315\u201322.","journal-title":"Int J Technol Assess Health Care"},{"key":"1_CR4","doi-asserted-by":"crossref","unstructured":"Kaltenthaler E, Boland A, Carroll C, Dickson R, Fitzgerald P, Papaioannou D. Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis. Health Technol Assess 2011;15(22):1\u2013iv.","DOI":"10.3310\/hta15220"},{"issue":"2\u20133","key":"1_CR5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.healthpol.2011.06.002","volume":"102","author":"C Carroll","year":"2011","unstructured":"Carroll C, Kaltenthaler E, Fitzgerald P, Boland A, Dickson R. A thematic analysis of the strengths and weaknesses of manufacturers\u2019 submissions to the NICE Single Technology Assessment (STA) process. Health Policy. 2011;102(2\u20133):136\u201344.","journal-title":"Health Policy"},{"key":"1_CR6","doi-asserted-by":"crossref","first-page":"e000562","DOI":"10.1136\/bmjopen-2011-000562","volume":"2","author":"EC Kaltenthaler","year":"2012","unstructured":"Kaltenthaler EC, Dickson R, Boland A, Carroll C, Fitzgerald P, Papaioannou D, Akehurst R. A qualitative study of manufacturers\u2019 submissions to the UK NICE single technology appraisal process. BMJ Open. 2012;2:e000562.","journal-title":"BMJ Open"},{"issue":"26","key":"1_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20260","volume":"20","author":"E Kaltenthaler","year":"2016","unstructured":"Kaltenthaler E, Carroll C, Hill-McManus D, Scope A, Holmes M, Rice S, et al. The use of exploratory analyses within the NICE Single Technology Appraisal process. Health Technol Assess. 2016;20(26):1\u201346.","journal-title":"Health Technol Assess"},{"key":"1_CR8","unstructured":"Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduce of narrative synthesis in systematic reviews. Swindon: ESRC Methods Programme; 2006. \n                        http:\/\/www.lancaster.ac.uk\/shm\/research\/nssr\/research\/dissemination\/publications\/NS_Synthesis_Guidance_v1.pdf\n                        \n                    . Accessed 11 April 16."},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2165\/0019053-200826120-00006","volume":"26","author":"L Barham","year":"2008","unstructured":"Barham L. Single technology appraisals by NICE: are they delivering faster guidance to the NHS? Pharmacoeconomics. 2008;26:1037\u201343.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"1_CR10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","volume":"26","author":"C McCabe","year":"2008","unstructured":"McCabe C, Claxton KF, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics. 2008;26(9):733\u201344.","journal-title":"Pharmacoeconomics"},{"key":"1_CR11","doi-asserted-by":"crossref","unstructured":"Carroll C, Kaltenthaler E, Tappenden P, Hill-McManus D, Scope A, Holmes M, et al. The type and impact of Evidence Review Group exploratory analyses in the NICE Single Technology (STA) process. Value Health (in press).","DOI":"10.1016\/j.jval.2016.08.729"},{"key":"1_CR12","unstructured":"Capecitabine for the treatment of advanced gastric cancer. NICE technology appraisal guidance TA191. 2010. \n                        https:\/\/www.nice.org.uk\/guidance\/ta191\n                        \n                    . Accessed 27 Apr 2015."},{"key":"1_CR13","unstructured":"Ivabradine for treating chronic heart failure. NICE technology appraisal guidance TA267. 2012. \n                        https:\/\/www.nice.org.uk\/guidance\/ta267\n                        \n                    . Accessed 2 May 2015."},{"issue":"8","key":"1_CR14","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jval.2011.06.007","volume":"14","author":"E Kaltenthaler","year":"2011","unstructured":"Kaltenthaler E, Papaioannou D, Boland A, Dickson R. The National Institute for Health and Clinical Excellence Single Technology Appraisal process: lessons from the first 4 years. Value Health. 2011;14(8):1158\u201365.","journal-title":"Value Health"}],"container-title":["PharmacoEconomics - Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-016-0001-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s41669-016-0001-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-016-0001-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T05:02:17Z","timestamp":1494824537000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s41669-016-0001-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1007\/s41669-016-0001-4","relation":{},"ISSN":["2509-4262","2509-4254"],"issn-type":[{"type":"print","value":"2509-4262"},{"type":"electronic","value":"2509-4254"}],"subject":[],"published":{"date-parts":[[2016,11,4]]}}}